List of largest biotechnology companies

A biotechnology company is a company whose products or services primarily use biotechnology methods for their production, design or delivery. The United Nations Convention on Biological Diversity defines 'biotechnology' as: "Any technological application that uses biological systems, living organisms, or derivatives thereof, to make or modify products or processes for specific use."[1] In other words, biotechology can be defined as the mere application of technical advances in life science to develop commercial products. Today, no comprehensive global database of biotech companies is available online, despite the fact that a free and open access project was launched in late 2014.[2]

Independent biotechnology companies

Rank Change Company Country Highest Market Cap ever (historical)(USD billions) Market Cap in Q2 2016 (USD billions)[3][4] Market Cap in 2015 (USD billions)[5] Market Cap in 2014 (USD billions)[6] Market Cap in 2013 (USD billions)
1SteadyJohnson & Johnson United States338.8 (July 2016)333.7 284.2 277.8 258.3
2SteadyRoche  Switzerland263.6 (February 2014)224.6 234.7 258.5 240.3
3IncreasePfizer United States310.5 (July 2000)213.5 199.3 205.4 196.0
4DecreaseNovartis  Switzerland275.2 (July 2015)196.5 206.1 229.8 195.0
5IncreaseMerck & Co. United States178.9 (January 2015)159.5 147.6 166.9 146.5
6IncreaseNovo Nordisk Denmark153.8 (June 2015)139.8 153.9 125.4 19.6
7IncreaseBristol-Myers Squibb United States115.3 (May 2015)122.8 114.8 97.6 87.2
8SteadyAmgen United States130.6 (December 2014)114.3 122.5 93.178.7
9DecreaseGilead Sciences United States179.6 (June 2013)111.1 145.8 109.078.4
10DecreaseSanofi France151.3 (September 2014)109.3 111.8 138.1 142.0
11SteadyGlaxoSmithKline United Kingdom174.9 (May 2006)105.5 97.6 128.9 129.6
12DecreaseAbbVie United States112.2 June 2015100.1 96.8 104.1 83.8
13SteadyAllergan Ireland133.5 July 201591.4 123.3 68.5 29.3
14SteadyEli Lilly & Co United States122.6 August 200086.9 93.4 76.6 57.0
15DecreaseBayer Germany129 March 201583.2 103.2 113.2 117.4
16DecreaseCelgene United States102.9 March 201576.4 94.1 89.5 69.2
17DecreaseAstraZeneca United Kingdom102.9 October 200676.4 85.8 88.9 74.6
18DecreaseAbbott Laboratories United States74.8 July 201557.8 67.0 67.9 59.3
19DecreaseBiogen United States111.7 March 201553.0 68.3 79.7 66.1
20DecreaseTeva Pharmaceutical Israel58.9 April 201045.9 55.9 49.0 37.8
21DecreaseStryker Corporation United States40.2 March 201644.8 34.7 35.7 28.4
22DecreaseRegeneron Pharmaceuticals Inc United States56.5 December 201536.7 56.5 42.0 27.4
23DecreaseShire Pharmaceuticals Ireland52.4 October 201436.3 41.0 42.4 28.1
24DecreaseAlexion Pharmaceuticals United States43.1 June 201526.1 43.0 36.8 26.2
25DecreaseBaxter International United States23.0 August 201525.0 20.9 21.620.5

Milestones

  • Q1 2016
    • Valeant exits the top-25 list with a decrease in market cap of $25 billion.
    • Allergan, plc exits the list due to its merger with Pfizer.
    • Stryker & Baxalta enter the top-25

  • Q2 2016
    • Baxalta has been removed from the list after being acquired by Shire.
    • Allergan, plc re-enters the list due to its merger with Pfizer being called-off.
    • As a result of Allergans re-inclusion, Mylan drops out of the top-25

Graphical representation

Graphical representation of the top-25 Biotechnology companies sorted by market capitalisation for Q2 of 2016

References

  1. ↑ "The Convention on Biological Diversity (Article 2. Use of Terms)." United Nations. 1992. Retrieved on February 6, 2008.
  2. ↑ Carlo Alberto Oppici, Filippo Giancarlo Martinelli. "BioDirecta". Retrieved 22 March 2015.
  3. ↑ "Healthcare – Google Finance".
  4. ↑ "Healthcare – Google Finance".
  5. ↑ "The World's Biggest Public Companies". Forbes.
  6. ↑ "• Top biotech and pharmaceutical companies market value 2015 - Statistic". Statista.


This article is issued from Wikipedia - version of the 7/16/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.